Patient recruitment: Today’s trends, tomorrow’s potential [interview with ACRPtv]

By some estimations, 80% of clinical trials are delayed or closed because researchers can’t find enough patients to take part in their clinical trials. This, of course, means that trial sponsors are losing money and sites are wasting time screening ineligible patients. But, it also means that countless patients continue to wait for new and potentially better treatment options.

Clinical trial patient recruitment is broken — but there’s a way to fix it. In this interview with ACRPtv, our CEO, Laurent Schockmel, discusses the current state of patient recruitment, how the bottleneck can be addressed, and how COVID-19 has impacted patient recruitment.